Want to know what it's like to study this course at uni? We've got all the key info, from entry requirements to the modules on offer. If that all sounds good, why not check out reviews from real students or even book onto an upcoming open days?
DM/MD - Doctor of Medicine
University of Liverpool
Full Time
DEC
2 years
Select a course option
DM/MD - Doctor of Medicine
University of Liverpool
Full Time
FEB-25
2 years
DM/MD - Doctor of Medicine
University of Liverpool
Full Time
DEC
2 years
DM/MD - Doctor of Medicine
University of Liverpool
Full Time
JAN
2 years
DM/MD - Doctor of Medicine
University of Liverpool
Part Time
FEB-25
4 years
DM/MD - Doctor of Medicine
University of Liverpool
Part Time
DEC
4 years
DM/MD - Doctor of Medicine
University of Liverpool
Part Time
JAN
4 years
Select a an exam type
Overview
The Department of Molecular and Clinical Cancer Medicine is the centre for large European pancreas studies aimed at examining the benefit of chemotherapy and chemoradiotherapy in the treatment of patients who have undergone surgery to remove pancreas cancer tissue.
Pancreatology is one of Liverpool’s recognised strengths with scientific expertise in Pancreatic cancer and pancreatitis and strong clinical and science leadership.
Research themes
Our research themes include:
Clinical trials aimed at determining the overall benefits of current treatments and evaluating the benefits of newly emerging treatments for pancreatic cancer. The Division of Surgery and Oncology is the centre for large European pancreas studies including the ESPAC clinical trials aimed at examining the benefit of chemotherapy and chemoradiotherapy (the combined use of chemotherapy and radiotherapy) in the treatment of patients who have undergone surgery to remove pancreas cancer tissue. There are major clinical trials in advanced pancreatic cancer (such as Gem-Cap) and developmental trials focusing on new biological agents such as the use of targeted super-antibodies and gene therapy. In the palliative care setting we are at the forefront of assessing and optimising novel methods of symptom and pain control. These and other trials that are available to patients at Liverpool will hopefully improve our understanding of the currently available treatments for pancreas cancer
Development and Co-ordination of the world's largest collection of families with Hereditary Pancreatitis and Familial Pancreas Cancer. Researchers in the department are currently working with these families to identify the underlying genetic cause of cancer in patients where the disease is inherited. In young patients with Hereditary Pancreatitis and Idiopathic Pancreatitis we are trialling novel treatments to inhibit or minimize the frequency or severity of the attacks
Identification of novel drug targets or diagnostic markers for pancreatic cancer. In an attempt to identify suitable drug targets or diagnostic markers for pancreatic adenocarcinoma, we have begun a systematic comparison of protein expression profiles from highly purified specimens of pancreatic adenocarcinoma and corresponding normal tissue. We have established the feasibility of the approach of purification of normal and cancer cells of pancreas by laser capture microdissection followed by visualisation of proteins by two dimensional gel electrophoresis and have identified several proteins whose expression is abnormally high or abnormally low in pancreatic cancer cells. Validation and follow-up of these proteins is ongoing
Applicants for postgraduate research study at Liverpool are normally expected to hold a UK first degree with a First Class or Upper Second Class degree classification, or a Second Class degree plus a Master’s degree. Equivalent international qualifications are also accepted, and their equivalence will be evaluated on the basis of the information provided by the National Academic Recognition and Information Centre (NARIC) as well as internal guidance based on our experience of a qualification’s suitability as a preparation for our programmes.
Students living in
Domestic
£4,786 per year
Students from Domestic
This fee applies to Channel Islands, Isle of Man and Republic of Ireland.
£29,750 per year
Students from EU
Faculty of Health and Life Sciences £29,750 (Band A). Self-funded, full-time international students studying a PhD programme classified as Band A will receive a £2,000 reduction in their fees for the first year only.
£29,750 per year
Students from International
Faculty of Health and Life Sciences £29,750 (Band A). Self-funded, full-time international students studying a PhD programme classified as Band A will receive a £2,000 reduction in their fees for the first year only.
Check out our
Liverpool city guide